Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development

B SHANGHAI, May 12, 2026 /PRNewswire/ — Insilico Medicine (“Insilico“, 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has…
posteditor
posteditor
Articles: 21727

Other News